Article
PCSK9 and Breast Cancer Survival: A Mendelian Randomization Study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 2 Jun 2026
Pott Janne, Mason Amy M, Salo Ville, Kettunen Johannes, Burgess Stephen
Abstract excerpt
BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects lipid metabolism. A recent study identified an association between rs562556 within the PCSK9 gene and breast cancer survival (BCS), suggesting PCSK9 inhibition as an early intervention strategy to prevent metastasizing breast cancer. We attempt to replicate these findings using genome-wide association study (GWAS) data and Mendelian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
